| Literature DB >> 25527145 |
Marcus B Jones1, Christopher P Montgomery2, Susan Boyle-Vavra3, Kenneth Shatzkes4, Rosslyn Maybank5, Bryan C Frank6, Scott N Peterson7, Robert S Daum8,9.
Abstract
BACKGROUND: Staphylococcus aureus is a human pathogen responsible for substantial morbidity and mortality through its ability to cause a number of human infections including bacteremia, pneumonia and soft tissue infections. Of great concern is the emergence and dissemination of methicillin-resistant Staphylococcus aureus strains (MRSA) that are resistant to nearly all β-lactams. The emergence of the USA300 MRSA genetic background among community associated S. aureus infections (CA-MRSA) in the USA was followed by the disappearance of USA400 CA-MRSA isolates.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25527145 PMCID: PMC4630920 DOI: 10.1186/1471-2164-15-1145
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
USA300 and USA 400 isolates
| USA Pulsotype | Strain name | ST | coverage | Year | Site of isolation or syndrome | Onset | SRA ID |
|---|---|---|---|---|---|---|---|
| USA400 | staph649 | ST1 | 99.02 | 2004 | Skin infection | CA | SRX026443 |
| USA400 | gsast11506 | ST1 | 99 | 2000 | CA | SRX026318 | |
| USA400 | gsast2674 | ST1 | 99 | 2000 | Respiratory, severe sepsis nec pneumonia | CA | SRX025928 |
| USA400 | gsastq2352 | ST1 | 99 | 2000 | Respiratory, severe sepsis nec pneumonia | CA | SRX025931 |
| USA300 | gsast10243 | ST8 | 98.15 | 2007 | Blood | CA | SRX026310 |
| USA300 | gsast10329 | ST8 | 99.27 | 2007 | Peritoneal/body fluid | HA | SRX026315 |
| USA300 | gsast1135 | ST8 | 98.15 | 2004 | Skin infection | CA | SRX026317 |
| USA300 | gsast11578 | ST8 | 99.3 | 2002 | CA | SRX025942 | |
| USA300 | gsast1185 | ST8 | 96.65 | 2004 | Skin infection | CA | SRX025925 |
| USA300 | gsast13205 | ST8 | 97.37 | 2008 | Blood, nec pneumonia, sepsis | SRX025943 | |
| USA300 | gsast2145 | ST8 | 99.28 | 2005 | Skin infection | CA | SRX026311 |
| USA300 | gsast5319 | ST8 | 99.32 | 2005 | Skin infection | CA | SRX026314 |
| USA300 | gsast9376 | ST8 | 97.91 | 2007 | Respiratory | HA | SRX025927 |
| USA300 | gsast9549 | ST8 | 99.26 | 2007 | Screen | HA | SRX025926 |
| USA300 | gsast9636 | ST8 | 99.28 | 2007 | Respiratory | HA | SRX025944 |
| USA300 | gsast9750 | ST8 | 98.82 | 2007 | Screen | HA | SRX025939 |
| USA300 | gsastca11 | ST8 | 95.94 | 1998 | CA | SRX025929 | |
| USA300 | staph923 | ST8 | 99.31 | 2004 | Skin infection | CA | SRX025930 |
Figure 1Role category analysis of USA300 and USA400 genes differentially expressed and growth. X- axis represents individual role categories based on gene function. Y-axis values indicate the mathematical difference in the number of genes significantly differentially expressed between USA300 and USA400 isolates during in vitro and in vivo growth. Positive values indicate a higher number of genes differentially expressed in the corresponding role category in USA300 isolate 923 compared to USA400 isolate 649. Negative values indicate a higher number of genes differentially expressed in the corresponding role category in USA400 isolate 649 compared to USA300 isolate 923. Blue bars indicate values from the 30 min in vitro time point; Yellow bars indicate 60 min in vitro time point; Green bars indicate 90 min in vitro time point; Maroon bars indicate 120 min in vitro time point; and Red bars indicate bars indicate the in vivo time point.